Company profile
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
Delivering meaningful innovation in medical dermatology.
- Industry
- Biotechnology Research
- Employees
- 454
- Headquarters
- Westlake Village, California
- Founded
- 2016
- LinkedIn followers
- 32,989
- Office locations
- 1
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) company summary
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a company in the Biotechnology Research industry, headquartered in Westlake Village, California, founded in 2016. On LinkedIn the company has around 454 employees and 32,989 followers. Warmrank detected 38 technologies across 25 categories on arcutis.com, including Animate.css, Anthropic, Atlassian. Its listed specialties include Biotechnology, Medical Dermatology, Drug Development, Inflammation, Immunology.
What technology does Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) use?
Warmrank detected 38 technologies on arcutis.com, last checked July 2026. Click any tool to see other companies that use it.
DocuSign
Open Graph
Popper
RSS
Webpack
Google Analytics
Linkedin Insight Tag
Microsoft ClarityJavaScript libraries
Tippy.js
jQuery
jQuery Migrate
Anthropic
Fastly
Unpkg
MariaDB
MySQL
reCAPTCHACaching
Varnish
WordPressCRM
SalesforceCustomer data platform
SegmentShow 14 more technologiesShow fewer technologies
Font scripts
Google Font APIMarketing automation
HubSpotPaaS
PantheonPage builders
WordPress Block EditorPerformance
Priority HintsProgramming languages
PHP
Yoast SEOSSL/TLS certificate authorities
Let's EncryptTag managers
Google Tag ManagerUI frameworks
Animate.cssVideo players
VimeoWeb servers
NginxWebmail
Microsoft 365WordPress plugins
Gravity FormsAbout Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is an early commercial stage biopharmaceutical company focused on developing and commercializing best-in-class products. Our strategy is to exploit recent innovations in inflammation and immunology to bring the best molecules to bear against validated physiologic targets known to treat dermatological diseases and disorders. Our management team has extensive expertise in the development and commercialization of medical dermatology products, having held key leadership roles at a number of leading dermatology companies and, collectively, has successfully developed more than 50 FDA-approved products. We believe that by leveraging our team’s unique experience and demonstrated expertise to identify, develop and commercialize best-in-class molecules against validated targets, we will be able to develop differentiated products in less time, at lower cost, and at substantially lower risk than other approaches. Arcutis' combination of vision, unmet medical need, experienced management and strategic approach has attracted support from leading investors in the life sciences sector.
Specialties
Where is Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) located?
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) lists 1 location.
Compare companies similar to Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) arcutis.com | Biotechnology Research | 454 | 2016 | Westlake Village, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
What does Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) do?
Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is an early commercial stage biopharmaceutical company focused on developing and commercializing best-in-class products. Our strategy is to exploit recent innovations in inflammation and immunology to bring the best molecules to bear against validated physiologic targets known to treat dermatological diseases and disorders. Our management team has extensive expertise in the development and commercialization of medical dermatology products, having held key leadership roles at a number of leading dermatology companies and, collectively, has successfully developed more than 50 FDA-approved products. We believe that by leveraging our team’s unique experience and demonstrated expertise to identify, develop and commercialize best-in-class molecules against validated targets, we will be able to develop differentiated products in less time, at lower cost, and at substantially lower risk than other approaches. Arcutis' combination of vision, unmet medical need, experienced management and strategic approach has attracted support from leading investors in the life sciences sector.
What technology does Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) use?
Warmrank detected 38 technologies on arcutis.com, including Animate.css, Anthropic, Atlassian, DocuSign, Fastly, Google Analytics, Google Font API, Google Tag Manager.
How many employees does Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) have?
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) has around 454 employees on LinkedIn.
Where is Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) headquartered?
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is headquartered in Westlake Village, California.
When was Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) founded?
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) was founded in 2016.
Build a lead list from companies like Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.